CANDESARTAN HIDROCLOROTIAZIDA AUROBINDO 8mg / 12.5mg tablets medication leaflet

C09DA06 candesartan cilexetil + hydrochlorothiazide • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Candesartan cilexetil and hydrochlorothiazide are used together for the treatment of high blood pressure, especially in patients who do not respond adequately to monotherapy. This combination combines an angiotensin II receptor antagonist (candesartan) and a thiazide diuretic (hydrochlorothiazide).

Candesartan helps relax blood vessels, while hydrochlorothiazide increases the elimination of excess water and salt through urine, thereby reducing blood volume and blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor blood pressure and electrolyte levels during treatment.

Side effects may include dizziness, fatigue, electrolyte imbalances, or, in rare cases, allergic reactions. Patients should inform their doctor of any unusual symptoms.

General data about CANDESARTAN HIDROCLOROTIAZIDA AUROBINDO 8mg / 12.5mg

Substance: candesartan cilexetil + hydrochlorothiazide

Date of last drug list: 01-10-2020

Commercial code: W66759009

Concentration: 8mg / 12.5mg

Pharmaceutical form: tablets

Quantity: 500

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: APL SWIFT SERVICES (MALTA) LIMITED - MALTA

Holder: AUROBINDO PHARMA ROMANIA S.R.L. - ROMANIA

Number: 12854/2019/01

Shelf life: 2 years

Concentrations available for candesartan cilexetil + hydrochlorothiazide

16mg/12.5mg, 32mg/12.5mg, 32mg/25mg, 8mg/12.5mg

Other substances similar to candesartan cilexetil + hydrochlorothiazide